Hepatobiliary scintigraphy of bile excretion after endoscopic ultrasound-guided hepaticogastrostomy for malignant biliary obstruction: a retrospective study in Japan
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Hepatobiliary scintigraphy (HBS) is used to evaluate bile excretion. This study aimed to evaluate biliary excretion during endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) using HBS. Methods: We retrospectively evaluated 78 consecutive patients with malignant extrahepatic biliary obstruction, who underwent HBS after EUS-HGS between April 2015 and July 2022. The peak time and decay rate were scored with 0, 1, or 2 points based on thresholds of 20 and 35 minutes, and 10% and 50%, respectively. A total score of 4 or 3 was considered indicative of good bile excretion, whereas scores of 2, 1, or 0 indicated poor bile excretion. Results: The good and poor bile excretion groups included 40 and 38 cases, respectively. The group with good bile excretion had a significantly longer time to recurrent biliary obstruction compared to the poor bile excretion group (not reached vs. 124 days, p=0.026). Multivariate analysis identified the site of obstruction as a significant factor influencing good bile excretion (odds ratio, 3.39; 95% confidence interval, 1.01–11.4, p=0.049), with superior bile excretion observed in cases involving upper biliary obstruction compared to middle or lower biliary obstruction. Conclusions: In patients with malignant biliary obstruction who underwent HGS, the site of obstruction is significantly associated with stent patency.
Abstract
Background/Aims: Hepatobiliary scintigraphy (HBS) is used to evaluate bile excretion. This study aimed to evaluate biliary excretion during endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) using HBS. Methods: We retrospectively evaluated 78 consecutive patients with malignant extrahepatic biliary obstruction, who underwent HBS after EUS-HGS between April 2015 and July 2022. The peak time and decay rate were scored with 0, 1, or 2 points based on thresholds of 20 and 35 minutes, and 10% and 50%, respectively. A total score of 4 or 3 was considered indicative of good bile excretion, whereas scores of 2, 1, or 0 indicated poor bile excretion. Results: The good and poor bile excretion groups included 40 and 38 cases, respectively. The group with good bile excretion had a significantly longer time to recurrent biliary obstruction compared to the poor bile excretion group (not reached vs. 124 days, p=0.026). Multivariate analysis identified the site of obstruction as a significant factor influencing good bile excretion (odds ratio, 3.39; 95% confidence interval, 1.01–11.4, p=0.049), with superior bile excretion observed in cases involving upper biliary obstruction compared to middle or lower biliary obstruction. Conclusions: In patients with malignant biliary obstruction who underwent HGS, the site of obstruction is significantly associated with stent patency.
참고문헌 (16)
- ASGE Standards of Practice Committee, "ASGE guideline on the role of endoscopy in the evalua tion and management of choledocholithiasis", Gastrointest Endosc, 89, pp.1075~1105 (2019)
- Hayat U, "EUS-guided versus percuta neous transhepatic cholangiography biliary drainage for obstructed distal malignant biliary strictures in patients who have failed endo scopic retrograde cholangiopancreatography : a systematic review and meta-analysis", Endosc Ultrasound, 11, pp.4~16 (2022)
- Hassan Z, "Percutaneous transhepatic cholangiography vs endoscopic ultrasound-guided biliary drainage : a systematic review", World J Gastroenterol, 28, pp.3514~3523 (2022)
- Boulay BR, "Endoscopic ultrasound-guided biliary drainage", Gastrointest Endosc Clin N Am, 28, pp.171~185 (2018)
- Isayama H, "Clinical practice guidelines for safe performance of endoscopic ultrasound", ultrasonography-guided bil iary drainage : 2018, 2019, pp.26, 249~269
- Ogura T, "Technical review of developments in endo scopic ultrasound-guided hepaticogastrostomy", Clin Endosc, 54, pp.651~659 (2021)
- Ogura T, "Expanding indications for endo scopic ultrasound-guided hepaticogastrostomy for patients with insufficient dilatation of the intrahepatic bile duct using a 22G nee dle combined with a novel 0. 018-inch guidewire(with video)", Dig Endosc, 34, pp.222~227 (2022)
- Okuno N, "B2 puncture with forward-view ing EUS simplifies EUS-guided hepaticogastrostomy(with video)", Endosc Ultrasound, 11, pp.319~324 (2022)
- Okuno N, "Novel drill dilator facilitates endo scopic ultrasound-guided hepaticogastrostomy", Dig Endosc, 35, pp.389~393 (2023)
- Kato-Azuma M, "TC-99m(Sn)-N-pyridoxylaminates : a new series of hepatobiliary imaging agents", J Nucl Med, 23, pp.517~524 (1982)
- Narabayashi I, "Quantitative analysis by digital computer of 99mTc-N-pyridoxyl-5-methyltryptophan(99mTc-PMT)hepatogram in diffuse parenchymal liver diseases", Eur J Nucl Med, 13, pp.285~287 (1987)
- Kobayashi M, "Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigra phy with 99mTc-N-pyridoxyl-5-methyltryptophan", Nucl Med Biol, 41, pp.338~342 (2014)
- Okuno N, "Risks of transesophageal endo scopic ultrasonography-guided biliary drainage", Gastrointest Interv, 6, pp.82~84 (2017)
- Isayama H, "TOKYO criteria 2014 for transpapillary biliary stenting", Dig Endosc, 27, pp.259~264 (2015)
- Yokoe M, "Tokyo Guidelines 2018 : diagnostic criteria and severity grading of acute cholecystitis(with videos)", J Hepatobiliary Pancreat Sci, 25, pp.41~54 (2018)
- Cotton PB, "A lexicon for endoscopic adverse events : report of an ASGE workshop", Gastrointest Endosc, 71, pp.446~454 (2010)